About Flag Therapeutics
Flag Therapeutics is a company based in Raleigh (United States) founded in 2013. Flag Therapeutics has raised $1.37 million across 5 funding rounds from investors including HHS and NCBiotech. Flag Therapeutics offers products and services including FLAG-003 and FLAG-094.
- Headquarter Raleigh, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Flag Therapeutics, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.37 M (USD)
in 5 rounds
-
Latest Funding Round
$72.5 K (USD), Seed
Jun 28, 2019
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Flag Therapeutics
Flag Therapeutics offers a comprehensive portfolio of products and services, including FLAG-003 and FLAG-094.
Small molecule treatment for DIPG and GBM cancers
Small molecule therapy for endometrial ovarian cancer
Funding Insights of Flag Therapeutics
Flag Therapeutics has successfully raised a total of $1.37M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $72.5 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Flag Therapeutics
Flag Therapeutics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and NCBiotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are incubated and funded in North Carolina.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Flag Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Flag Therapeutics
Investment portfolio details for Flag Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Flag Therapeutics
Detailed financials for Flag Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Flag Therapeutics Comparisons
Peer comparison for Flag Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Flag Therapeutics
Detailed competitors of Flag Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Flag Therapeutics
Complete news archive for Flag Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flag Therapeutics
Flag Therapeutics was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Flag Therapeutics is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Flag Therapeutics is a funded company, having raised a total of $1.37M across 5 funding rounds to date.
Flag Therapeutics was founded in 2013 in Raleigh, United States, within the biotechnology sector focused on oncology. Small molecule therapeutics are developed using a proprietary platform that produces water-soluble compounds designed to target and bind cancer cells. The pipeline includes FLAG-003, a lead candidate for treating Diffuse Intrinsic Pontine Glioma and glioblastoma multiforme, addressing unmet needs in difficult cancers.
Flag Therapeutics offers FLAG-003 and FLAG-094.